Accéder au contenu
Merck
  • Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.

Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.

Carbohydrate polymers (2020-07-29)
Laura Marcela Forero Ramirez, Elise Gobin, Rachida Aid-Launais, Clément Journe, Fernanda C Moraes, Luc Picton, Didier Le Cerf, Didier Letourneur, Cédric Chauvierre, Frédéric Chaubet
RÉSUMÉ

Early detection of thrombotic events remains a big medical challenge. Dextran-based submicronic particles bearing Gd(DOTA) groups and functionalized with fucoidan have been produced via a simple and green water-in-oil emulsification/co-crosslinking process. Their capacity to bind to human activated platelets was evidenced in vitro as well as their cytocompatibility with human endothelial cells. The presence of Gd(DOTA) moieties was confirmed by elemental analysis and total reflection X-ray fluorescence (TRXF) spectrometry. Detailed characterization of particles was performed in terms of size distribution, morphology, and relaxation rates. In particular, longitudinal and transversal proton relaxivities were respectively 1.7 and 5.0 times higher than those of DOTAREM. This study highlights their potential as an MRI diagnostic platform for atherothrombosis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Trisodium trimetaphosphate, ≥95%
Sigma-Aldrich
3-Chloropropylamine hydrochloride, 98%
Sigma-Aldrich
3,3′-Dihexyloxacarbocyanine iodide, 98%